222 related articles for article (PubMed ID: 28257933)
1. Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival.
Robertson A; Mohamed TM; El Maadawi Z; Stafford N; Bui T; Lim DS; Cartwright EJ; Oceandy D
Stem Cell Res; 2017 Apr; 20():42-49. PubMed ID: 28257933
[TBL] [Abstract][Full Text] [Related]
2. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
3. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
[TBL] [Abstract][Full Text] [Related]
4. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
[TBL] [Abstract][Full Text] [Related]
6. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.
Qin H; Blaschke K; Wei G; Ohi Y; Blouin L; Qi Z; Yu J; Yeh RF; Hebrok M; Ramalho-Santos M
Hum Mol Genet; 2012 May; 21(9):2054-67. PubMed ID: 22286172
[TBL] [Abstract][Full Text] [Related]
8. Hippo kinases Mst1 and Mst2 maintain NK cell homeostasis by orchestrating metabolic state and transcriptional activity.
Feng P; Luo L; Yang Q; Meng W; Guan Z; Li Z; Sun G; Dong Z; Yang M
Cell Death Dis; 2024 Jun; 15(6):430. PubMed ID: 38898027
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression.
Song H; Mak KK; Topol L; Yun K; Hu J; Garrett L; Chen Y; Park O; Chang J; Simpson RM; Wang CY; Gao B; Jiang J; Yang Y
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1431-6. PubMed ID: 20080598
[TBL] [Abstract][Full Text] [Related]
10. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
11. Mst1 deletion attenuates renal ischaemia-reperfusion injury: The role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3β-p53 signalling pathway.
Li H; Feng J; Zhang Y; Feng J; Wang Q; Zhao S; Meng P; Li J
Redox Biol; 2019 Jan; 20():261-274. PubMed ID: 30384260
[TBL] [Abstract][Full Text] [Related]
12. The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.
Wu H; Xiao Y; Zhang S; Ji S; Wei L; Fan F; Geng J; Tian J; Sun X; Qin F; Jin C; Lin J; Yin ZY; Zhang T; Luo L; Li Y; Song S; Lin SC; Deng X; Camargo F; Avruch J; Chen L; Zhou D
Cell Rep; 2013 May; 3(5):1663-77. PubMed ID: 23684612
[TBL] [Abstract][Full Text] [Related]
13. MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Maille E; Brosseau S; Hanoux V; Creveuil C; Danel C; Bergot E; Scherpereel A; Mazières J; Margery J; Greillier L; Audigier-Valette C; Moro-Sibilot D; Molinier O; Corre R; Monnet I; Gounant V; Langlais A; Morin F; Levallet G; Zalcman G
Br J Cancer; 2019 Feb; 120(4):387-397. PubMed ID: 30739911
[TBL] [Abstract][Full Text] [Related]
14. Mammalian sterile 20 kinase 1 and 2 are important regulators of hematopoietic stem cells in stress condition.
Lee DH; Kim TS; Lee D; Lim DS
Sci Rep; 2018 Jan; 8(1):942. PubMed ID: 29343826
[TBL] [Abstract][Full Text] [Related]
15. Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.
Chao Y; Wang Y; Liu X; Ma P; Shi Y; Gao J; Shi Q; Hu J; Yu R; Zhou X
J Neurooncol; 2015 Jan; 121(2):279-88. PubMed ID: 25373346
[TBL] [Abstract][Full Text] [Related]
16. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
Lin C; Yao E; Chuang PT
Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
[TBL] [Abstract][Full Text] [Related]
17. mTORC2 regulates cardiac response to stress by inhibiting MST1.
Sciarretta S; Zhai P; Maejima Y; Del Re DP; Nagarajan N; Yee D; Liu T; Magnuson MA; Volpe M; Frati G; Li H; Sadoshima J
Cell Rep; 2015 Apr; 11(1):125-36. PubMed ID: 25843706
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors.
Pfaff N; Liebhaber S; Möbus S; Beh-Pajooh A; Fiedler J; Pfanne A; Schambach A; Thum T; Cantz T; Moritz T
Stem Cell Res; 2017 Apr; 20():70-75. PubMed ID: 28314201
[TBL] [Abstract][Full Text] [Related]
19. Non-canonical Hippo signaling regulates immune responses.
Chen L
Adv Immunol; 2019; 144():87-119. PubMed ID: 31699221
[TBL] [Abstract][Full Text] [Related]
20. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
